Cargando…

S6.5b Genomics and metagenomics of Madurella mycetomatis

S6.5 EFFORTS OF IMPROVING THE MANAGEMENT OF MYCETOMA: WORKING TOWARDS THE 2030 GOALS, SEPTEMBER 22, 2022, 4:45 PM - 6:15 PM: : Mycetoma is a debilitating disease recognized as a neglected tropical disease by the World Health Organization. The etiology of mycetoma is poorly understood; ∼ 60% of ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Litvintseva, Anastasia, Bakhiet, Sahar, Gade, Lalitha, Bagal, Ujwal, Wagner, Darlene, Siddig, Emmanuel Edwar, Mhmoud, Najwa Adam, Fahal, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554583/ http://dx.doi.org/10.1093/mmy/myac072.S6.5b

Ejemplares similares

Genomics and metagenomics of Madurella mycetomatis, a causative agent of black grain mycetoma in Sudan
por: Litvintseva, Anastasia P., et al.
Publicado: (2022)

S4.5c Using serum beta-glucan measurements and sequencing of the Madurella mycetomatis azole target gene to predict therapeutic outcome during azole treatment in human mycetoma
por: Nyuykonge, Bertrand, et al.
Publicado: (2022)

Madurella mycetomatis grains within a eumycetoma lesion are clonal
por: Nyuykonge, Bertrand, et al.
Publicado: (2022)

Epidemiological cut‐off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma
por: Nyuykonge, Bertrand, et al.
Publicado: (2022)

The Combination of Amoxicillin-Clavulanic Acid and Ketoconazole in the Treatment of Madurella mycetomatis Eumycetoma and Staphylococcus aureus Co-infection
por: Mhmoud, Najwa A., et al.
Publicado: (2014)

Th-1, Th-2 Cytokines Profile among Madurella mycetomatis Eumycetoma Patients
por: Nasr, Amre, et al.
Publicado: (2016)

Madurella mycetomatis Is Highly Susceptible to Ravuconazole
por: Ahmed, Sarah Abdalla, et al.
Publicado: (2014)

A Histopathological Exploration of the Madurella mycetomatis Grain
por: Ibrahim, Anahid Izzat, et al.
Publicado: (2013)

Mycetoma due to Madurella mycetomatis
por: Sigera, L.S.M., et al.
Publicado: (2020)

Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects
por: Elkheir, Lamis Y. M., et al.
Publicado: (2020)

The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach
por: Lim, Wilson, et al.
Publicado: (2020)

A Madurella mycetomatis Grain Model in Galleria mellonella Larvae
por: Kloezen, Wendy, et al.
Publicado: (2015)

Metagenomic detection of eumycetoma causative agents from households of patients residing in two Sudanese endemic villages in White Nile State
por: Santona, Antonella, et al.
Publicado: (2022)

Madurella mycetomatis-Induced Massive Shoulder Joint Destruction: A Management Challenge
por: Scolding, Peter S., et al.
Publicado: (2016)

Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim
por: Lim, Wilson, et al.
Publicado: (2020)

The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo
por: Konings, Mickey, et al.
Publicado: (2023)

Proteomic analysis of the processes leading to Madurella mycetomatis grain formation in Galleria mellonella larvae
por: Sheehan, Gerard, et al.
Publicado: (2020)

Active Matrix Metalloprotease-9 Is Associated with the Collagen Capsule Surrounding the Madurella mycetomatis Grain in Mycetoma
por: Geneugelijk, Kirsten, et al.
Publicado: (2014)

Chaetomium atrobrunneum causing human eumycetoma: The first report
por: Mhmoud, Najwa A., et al.
Publicado: (2019)

Draft Genome Sequences of Three Clinical Isolates of Madurella mycetomatis, the Major Cause of Black-Grain Mycetoma
por: Khidir, El Shiekh, et al.
Publicado: (2020)

The In Vitro Antifungal Activity of Sudanese Medicinal Plants against Madurella mycetomatis, the Eumycetoma Major Causative Agent
por: Elfadil, Hassabelrasoul, et al.
Publicado: (2015)

Eumycetoma by Madurella mycetomatis with 30 years of evolution: therapeutic challenge
por: Sampaio, Felipe Maurício Soeiro, et al.
Publicado: (2013)

Two simultaneous mycetomas caused by Fusarium verticillioides and Madurella mycetomatis
por: Bonifaz, Alexandro, et al.
Publicado: (2017)

Pulmonary Madurella mycetomatis mycetoma secondary to knee eumycetoma, Senegal
por: Diongue, Khadim, et al.
Publicado: (2021)

S4.5d Comparing the diagnostic performance of the commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the gold standard
por: Siddig, Emmanuel, et al.
Publicado: (2022)

P445 Clinical evaluation of the performance of the most commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the golden standard
por: Siddig, Emmanuel, et al.
Publicado: (2022)

Genome Sequence of Madurella mycetomatis mm55, Isolated from a Human Mycetoma Case in Sudan
por: Smit, Sandra, et al.
Publicado: (2016)

A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma–A Retrospective Study
por: Verwer, Patricia E. B., et al.
Publicado: (2015)

Peripheral Blood Mononuclear Cells of Mycetoma Patients React Differently to Madurella mycetomatis Antigens than Healthy Endemic Controls
por: Elagab, Ehab A. M., et al.
Publicado: (2013)

Specific and sensitive loop-mediated isothermal amplification (LAMP) method for Madurella strains, eumycetoma filamentous fungi causative agent
por: Yoshioka, Isato, et al.
Publicado: (2023)

The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma
por: Konings, Mickey, et al.
Publicado: (2021)

Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella
por: Lim, Wilson, et al.
Publicado: (2022)

Madurella Mycetomatis Infection Following Allogenic Stem Cell Transplantation for Aplastic Anemia
por: Sharma, Sanjeev Kumar, et al.
Publicado: (2012)

Madurella mycetomatis infection of the buttock in an Eritrean refugee in Switzerland: a case report
por: Mekoguem, Carine, et al.
Publicado: (2019)

Development and Validation of an In Vitro Resazurin-Based Susceptibility Assay against Madurella mycetomatis
por: Abd Algaffar, S. O., et al.
Publicado: (2021)

S4.5b A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—pharmacokinetic results
por: Brüggemann, Roger, et al.
Publicado: (2022)

The Accuracy of Histopathological and Cytopathological Techniques in the Identification of the Mycetoma Causative Agents
por: Siddig, Emmanuel Edwar, et al.
Publicado: (2019)

P033 Genomic epidemiology of the antifungal-resistant dermatophytosis epidemic, India, 2017-2019
por: Bagal, Ujwal, et al.
Publicado: (2022)

Epitope-Based Peptide Vaccine Against Fructose-Bisphosphate Aldolase of Madurella mycetomatis Using Immunoinformatics Approaches
por: Mohammed, Arwa A, et al.
Publicado: (2018)

Phylogenetic Analysis of the Complete Mitochondrial Genome of Madurella mycetomatis Confirms Its Taxonomic Position within the Order Sordariales
por: van de Sande, Wendy W. J.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jle384ktn1fporbnlohn8k9hnd